344
Q. Chen et al.
74. Z. Yehoshua, P.J. Rosenfeld, T.A. Albini, Current clinical trials in dry AMD and the definition
of appropriate clinical outcome measures. Seminars Ophthalmology 26(3), 167–180 (2011)
75. S. Bearelly, F.Y. Chau, A. Koreishi et al., Spectral domain optical coherence tomography
imaging of geographic atrophy margins. Ophthalmology 116(9), 1762–1769 (2009)
76. J.L. Dunaief, T. Dentchev, G.S. Ying, A.H. Milam, The role of apoptosis in age-related macular
degeneration. Arch. Ophthalmol. 120(11), 1435–1442 (2002)
77. G.S. Hageman, P.J. Luthert, Chong N.H. Victor et al., An integrated hypothesis that considers
drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface
in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20(6), 705–732 (2001)
78. G. Lutty, J. Grunwald, A.B. Majji, M. Uyama, S. Yoneya, Changes in choriocapillaris and
retinal pigment epithelium in age-related macular degeneration. Mol. Vis. 5, 35 (1999)
79. D.S. McLeod, M. Taomoto, T. Otsuji et al., Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 43(6),
1986–1993 (1993)
Précédent

- 348/387

Suivant